At an early stage of obesity, while MCP-1, the pivotal monocyte chemoattractant, is not elevated, resident macrophage proliferation in situ is significantly enhanced greatly, depending on the IL-4/Stat6 pathway. Here, IL4 is linked to obesity disorder.